The Cudeca Foundation has joined forces with the Institute of Biomedical Research of Malaga (IBIMA) in a four-year initiative that aims to improve care for terminally-ill patients by addressing the physical, psychological and social needs of patients, families and volunteers.
To achieve these objectives, Cudeca will collaborate with a team led by Juan Daniel Prados, a researcher from the department of Pharmacology.
The project aims to promote scientific activity by generating knowledge derived from the collaboration of Cudeca and IBIMA on clinical research programmes and patient care, as well as expanding the interdisciplinary approach and integrity of patients with cancer and other life-threatening illnesses.
The presentation of the project was held this week in Benalmádena and was attended by the the town's mayor, Víctor Navas; councillor for Health, Ana Isabel González, and Cudeca medical director, Marisa Martín.
Also present were IBIMA scientific director, Francisco Tinahones, and general manager of the institute, José Miguel Guzmán.
Marisa Martín stated that the project will include improving the care for patients in the final phase of life, through epidemiological studies, clinical trials, and qualitative studies, to enable the improvement of the well-being of both patients and their families.
Both organisations also undertake to promote competitive research, public or private, national or EU projects, giving groups and researchers involved a greater ability to get resources that finance research in palliative care.
The research will take place at the IBIMA institution in Malaga and at the Cudeca Hospice in Benalmádena over the next four years, with the possibility of extending the collaboration further.
"Cudeca and IBIMA will collaborate on an important initiative that will focus on areas of research that are strategic for the institute," Francisco Tinahones explained.